CXCL13-neutralizing Antibody Alleviate Chronic Skeletal Muscle Degeneration in a Mouse Model.

Zhongcheng Xie Jimin YangChunmeng JiaoHui ChenSiyu OuyangZhiyang LiuQin HouJifeng Liu

Published in: Current molecular medicine (2024)

Our study reveals the underlying therapeutic implications of CXCL13 inhibition for clinical intervention in skeletal muscle degeneration, thereby improving patient prognosis.

Keyphrases

skeletal muscle
mouse model
insulin resistance
randomized controlled trial
case report